Discharge disposition and clinical outcomes of patients hospitalized with COVID-19.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
May 2023
Historique:
received: 22 07 2022
revised: 26 01 2023
accepted: 26 01 2023
medline: 11 4 2023
pubmed: 4 2 2023
entrez: 3 2 2023
Statut: ppublish

Résumé

By better understanding the long-term effects of COVID-19 and assessing rehabilitation placement among the patients in our study, we hope to determine the predictors of rehabilitation needs in individuals suffering from the long-term sequelae of COVID-19. A retrospective chart review was performed of adult patients with a positive COVID-19 polymerase chain reaction test among multiple hospitals in a regional health system. The main outcomes measured were discharge disposition, total length of hospital stay, and overall all-cause mortality and readmission rates within 30 and 90 days of discharge. Of the 2502 patients included in the study, we found that 65.2% were discharged to home, while the remaining patients were discharged to home healthcare (33.6%), skilled nursing facilities (31.7%), or long-term acute rehabilitation centers (11.6%). The overall all-cause mortality rate at 30 and 90 days were 2.7% and 4.4%, respectively. The overall all-cause 30-day and 90-day readmission rates were 7.0% and 7.6%, respectively. Younger age and shorter hospitalization stays were the most important predictors of home discharge. Discharge to home was also significantly associated with lower all-cause mortality rates at 30 and 90 days after discharge.

Identifiants

pubmed: 36736991
pii: S1201-9712(23)00040-1
doi: 10.1016/j.ijid.2023.01.038
pmc: PMC9891781
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-5

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflicts of interest to declare

Références

Arch Phys Med Rehabil. 2021 Mar;102(3):351-358
pubmed: 33278363
JAMA. 2021 Apr 20;325(15):1525-1534
pubmed: 33729425
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Am J Manag Care. 2021 Aug;27(8):309-310
pubmed: 34460171
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238
Cleve Clin J Med. 2021 May 3;88(5):267-272
pubmed: 33941600
Healthc (Amst). 2021 Mar;9(1):100512
pubmed: 33383393
Circ Heart Fail. 2011 May;4(3):293-300
pubmed: 21447803
J Am Med Dir Assoc. 2020 Nov;21(11):1555-1559.e2
pubmed: 32978065
MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1695-1699
pubmed: 33180754
Eur Respir J. 2021 Jun 24;57(6):
pubmed: 33795319

Auteurs

Shiv Patel (S)

School of Medicine, Creighton University, Omaha, USA. Electronic address: shiv.amit.patel@gmail.com.

Gia Thinh Truong (GT)

School of Medicine, Creighton University, Omaha, USA. Electronic address: GiaThinhTruong@creighton.edu.

Ajay Rajan (A)

School of Medicine, Creighton University, Omaha, USA. Electronic address: AjayRajan@creighton.edu.

Zachary Creech (Z)

School of Medicine, Creighton University, Omaha, USA. Electronic address: ZacharyCreech@creighton.edu.

Ryan Walters (R)

Department of Clinical Research, Creighton University, Omaha, USA. Electronic address: RyanWalters@creighton.edu.

Ian Ng (I)

Department of Clinical Research, Creighton University, Omaha, USA. Electronic address: IanNg@creighton.edu.

Christopher Destache (C)

School of Pharmacy and Health Professions, Creighton University, Omaha, USA. Electronic address: ChrisDestache@creighton.edu.

Renuga Vivekanandan (R)

Division of Infectious Disease, Creighton University School of Medicine, Omaha, USA. Electronic address: RenugaVivekanandan@creighton.edu.

Maureen Tierney (M)

Department of Medicine, Creighton University School of Medicine, Omaha, USA. Electronic address: MaureenTierney@creighton.edu.

Manasa Velagapudi (M)

Division of Infectious Disease, Creighton University School of Medicine, Omaha, USA. Electronic address: ManasaVelagapudi@creighton.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH